8622 — Joyzyme Share News
0.000.00%
- HK$115.98m
- HK$73.19m
- CNY28.28m
Brief: Huakang Biomedical Trading In Co's Shares Halted
Brief: Huakang Biomedical Says Zhang Shuguang Resigns As Executive Director And Chairman
Brief: Huakang Biomedical Announces Zhang Yujing Appointed As Executive Director
Brief: Huakang Biomedical To Acquire 51% Interest In Hunan Keyue Biotechnology
Brief: Huakang Biomedical Announces Lapse Of Placing Agreement Dated 31 Dec
Brief: Huakang Biomedical Says Chairman Sold Entire Issued Share Capital In Crystal Grant
Brief: Huakang Biomedical To Place Up To 100 Million New Shares
Brief: Huakang Biomedical Updates On New Business Activity
Brief: Huakang Biomedical Announces Placing Of New Shares Under General Mandate
Brief: Huakang Biomedical Sees Loss Attributable Of Not More Than RMB5.8 Mln For FY
Brief: Huakang Biomedical Announces Memorandum Of Understanding In Relation To A Potential Cooperation In Sale And Distribution
Brief: Huakang Biomedical Says To Place Up To 62 Million New Shares For Hk$0.096 Per Placing Share
Brief: Huakang Biomedical Says Controlling Shareholder Sold 65.2 Million Shares Of Co
Brief: Huakang Biomedical Announces Disposal Of Shares By A Controlling Shareholder
Brief: Huakang Biomedical Holdings Announces Placing Of New Shares Under General Mandate
Brief: Huakang Biomedical Announces Disposal Of Shares By Controlling Shareholder
Brief: Huakang Biomedical Says 544,000 Shares Of Co Held By Crystal Grant Were Sold On Market
Brief: Huakang Biomedical Announces Acquisition Of 19% Stake Of Hainan Jinnuosai Medical Technology
Brief: Huakang Biomedical Says Trading In Shares Will Be Halted